HRTX

Heron Therapeutics
HRTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$294.45M
EV
$421.02M
Shares Outstanding
152.56M
Beta
1.17

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$6.25
P/E 2025E
226.00x
P/Revenue 2025E
1.86x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Heron Therapeutics, Inc.

gainify
HRTX

Heron Therapeutics, Inc.

HRTX

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug deliv...

Sector

Healthcare

Industry

Biotechnology

CEO

Collard, Craig

Employees

122

IPO Date

1987-08-26

Headquarters

4242 Campus Point Court, Suite 200, San Diego, California, 92121, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.